Antineoplastic Drugs
Showing 1 - 25 of >10,000
Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))
Recruiting
- Cancer
- Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Jul 18, 2022
Nurses Internal Contamination by Antineoplastic Drugs.
Completed
- Antineoplastic Drugs Contamination Prevalence
- Nurses urine samples
-
Bordeaux, France
- +2 more
May 14, 2020
DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG TREATMENT IN
Unknown status
- Adherence, Medication
- Therapeutic Adherence
- (no location specified)
Oct 2, 2020
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Safe Infusion Device in Reducing Occupational Exposure of Nurses
Completed
- Cancer
- Safe Infusion Device
-
Saint-Priest-en-Jarez, FranceInstitut de Cancérologie Lucien Neuwirth
Sep 23, 2019
Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)
Recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron Transdermal Delivery System
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 19, 2022
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
Efficacy and Safety of ICIs as First-line Therapy for Advanced
Not yet recruiting
- Malignant Tumor
- +2 more
-
Chongqing, Chongqing, Chinathe second affiliated hospital of Army medical university
May 16, 2023
Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)
Recruiting
- Breast Cancer
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 13, 2023
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Vacuolar ATPase and Drug Resistance of High Grade Gliomas
Recruiting
- Glioblastoma Multiforme
-
Monza, ItalyAzienda Socio Sanitaria Territoriale Monza - Ospedale San Gerard
Apr 11, 2022
Oral Complications in Hematological Malignancies
Not yet recruiting
- Hematologic Malignancy
-
Assiut, EgyptAssiut university
Mar 6, 2023
Computation Prediction of Drug Response Based on Omics Data
Enrolling by invitation
- Breast Cancer
- virtual anti-cancer drug
-
Beijing, Beijing, ChinaShuhua Zhao
Apr 25, 2023
Reporting of AdVerse Events Associated With AnTicAncerRapy
Recruiting
- Cancer
- Antineoplastic and Immunomodulating Agents
-
Caen, Basse Normandie, FranceAlexandre Joachim
Jan 4, 2021
Myocardial Injury and Intestinal Flora Changes Associated With
Recruiting
- Cancer Therapy-related Cardiovascular Toxicity
- Antitumor drugs
-
Beijing, ChinaZhenyu Tian
Feb 6, 2023
Dedifferentiated Liposarcoma Patients in China
Not yet recruiting
- Dedifferentiated Liposarcoma
-
Beijing, ChinaBeijing Jishuitan hospital
Oct 30, 2023
Ovarian Cancer Trial in Roma (Blood sample)
Recruiting
- Ovarian Cancer
- Blood sample
-
Roma, ItalyPoliclinico Universitario Agostino Gemelli
Oct 10, 2023
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab
Not yet recruiting
- Localized Muscle Invasive Bladder Urothelial Carcinoma
- Muscle-Invasive Bladder Carcinoma
- Sacituzumab govitecan
- Adaptive Radiotherapy
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 18, 2023
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
Cytokine Release Syndrome, Covid-19 Trial in Sao Luis (Tocilizumab 180 MG/ML, Methylprednisolone Sodium Succinate)
Terminated
- Cytokine Release Syndrome
- Covid-19
- Tocilizumab 180 MG/ML
- Methylprednisolone Sodium Succinate
-
Sao Luis, MA, BrazilHospital Sao Domingos
Mar 14, 2022
Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)
Recruiting
- Adenocarcinoma of Stomach
- Gentuximab Injection
- Gentuximab Injection Placebo
-
Shanghai, Shanghai, ChinaShanghai Dongfang Hospital
Jun 16, 2023
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2023